Market Closed -
Other stock markets
|
After market 03:59:40 pm | |||
5.445 EUR | -0.82% | 5.423 | -0.40% |
Apr. 25 | Transcript : Nanobiotix S.A., Q4 2023 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Nanobiotix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 23.53M 25.23M | Sales 2025 * | 38.34M 41.12M | Capitalization | 259M 277M |
---|---|---|---|---|---|
Net income 2024 * | -40M -42.89M | Net income 2025 * | -28M -30.02M | EV / Sales 2024 * | 12 x |
Net Debt 2024 * | 24.35M 26.11M | Net cash position 2025 * | 52.9M 56.73M | EV / Sales 2025 * | 5.37 x |
P/E ratio 2024 * |
-7.25
x | P/E ratio 2025 * |
-18.9
x | Employees | 101 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.72% |
Latest transcript on Nanobiotix
1 week | -4.52% | ||
Current month | -3.68% | ||
1 month | -1.61% | ||
3 months | -27.19% | ||
6 months | -5.67% | ||
Current year | -17.32% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Lévy
CEO | Chief Executive Officer | 53 | 03-03-03 |
Bart van Rhijn
DFI | Director of Finance/CFO | 52 | 21-05-31 |
Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
CHM | Chairman | 58 | 21-05-24 |
Enno Spillner
BRD | Director/Board Member | 55 | 14-06-17 |
Alain Herrera
BRD | Director/Board Member | 74 | 11-06-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 5.445 | -0.82% | 18 314 |
24-04-29 | 5.49 | +0.73% | 29,621 |
24-04-26 | 5.45 | +0.93% | 25,481 |
24-04-25 | 5.4 | -2.44% | 26,330 |
24-04-24 | 5.535 | -3.74% | 45,258 |
Real-time Euronext Paris, April 30, 2024 at 06:17 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.32% | 277M | |
+1.77% | 42.86B | |
+45.15% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- NANO Stock